Speaker Profile
Ph.D., Senior Vice President, Research & Development, Castle Biosciences
Biography
Bob Cook joined Castle Biosciences in 2011 and currently serves as Senior Vice President, Research & Development. Dr. Cook joined Castle Biosciences following a postdoctoral fellowship at Baylor College of Medicine, where he focused on the genetic regulation of rare ovarian granulosa cell tumors. In his current position, Dr. Cook oversees research and development at Castle. He previously completed his doctoral work in biochemistry, molecular biology and cellular biology at Northwestern University, with a focus on the structural characteristics of protein hormones important for regulating the reproductive system. He received a B.S. degree in molecular biology from Temple University in Philadelphia. Dr. Cook is an author of many medical and scientific publications and a co-inventor of several of Castle Biosciences' technologies.
Talk
Improving Patient Care and Outcomes Using Advanced Genomics
Advanced molecular diagnostics are shifting the treatment paradigm for patients with cancers by enabling personalized and risk-aligned disease management decisions. This talk will explore the potential of genomic testing in skin cancers to guide more informed patient care decisions that can improve patient outcomes.
Genomic Profiling Showcase:
Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company focused on improving health through innovative tests that guide patient care. Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
